Daniela Cipolletta
Senior Director, Immunology Seismic Therapeutics
Daniela Cipolletta is Senior Director of Immunology at Seismic Therapeutic, where she leads the generation of novel therapies for autoimmune diseases. With over 20 years of experience in immunology, she has held positions at Novartis, Amgen, and Tempero (a GSK company), focusing on immune modulation across various disease areas. Dr. Cipolletta earned her Ph.D. in Immunology from the European School of Molecular Medicine and completed postdoctoral training at Harvard Medical School, where she researched tissue-resident regulatory T cells.
Seminars
Thursday 10th December 2026
Engineering Next-Generation Biologics to Enhance Selectivity, Durability & Clinical Impact in Complement Therapeutics
11:00 am
- Developing novel biologics, including bispecific antibodies, fusion proteins and engineered complement regulators, to improve therapeutic performance
- Optimizing pharmacokinetics, tissue targeting and mechanism of action to enhance efficacy while minimizing treatment burden
- Leveraging advances in protein engineering to create differentiated therapies across complement-mediated diseases
NEW SPEAKING COMPANY
